Iofina plc holds a distinctive position within the FTSE AIM All Share Index as a specialist producer of iodine and iodine-based chemicals in the United States. Readers should check the company's latest announcements for current production, results and any new plant developments.
What the company does
Iofina extracts iodine from brine water produced as a by-product of oil and gas operations. Its approach involves building iodine extraction plants, known by the company as IOsorb plants, alongside oil and gas facilities, primarily in Oklahoma, where brine with suitable iodine concentrations is available. By capturing iodine from water that would otherwise be reinjected or disposed of, the company has developed a niche source of supply.
Alongside crystalline iodine production, the group operates a specialty chemicals business that manufactures iodine derivatives and halogen-based products used in a range of applications. Iodine itself has uses in sectors including medical imaging contrast media, pharmaceuticals, animal nutrition, disinfectants, electronics and industrial chemicals. Combining raw iodine production with downstream chemicals gives the company two related revenue streams and a degree of vertical integration that is unusual for a business of its size.
Latest developments
Investors should consult the company's announcements and investor pages for its latest production updates, construction of new plants, results and commentary on iodine pricing. Historically, Iofina's communications have focused on output volumes, new plant commissioning and the performance of its chemicals business.
Financial and dividend picture
Iofina's revenue depends on the volume of iodine it produces and sells and on the prevailing iodine price, along with sales of its derivative products. Its profitability is also influenced by the operating costs of its plants and by investment in new capacity. The company has historically focused on growth and on strengthening its balance sheet rather than on dividends. Investors should review the latest annual and interim accounts for current information on revenue, earnings, cash and any borrowing.
Sector and index context
As a constituent of the FTSE AIM All Share Index, Iofina sits within LSE's chemicals and natural resources space, although its business model differs from typical miners. The global iodine market is relatively concentrated, with a large share of supply coming from Chilean producers that extract iodine from caliche ore and from producers in Japan. Iofina's US-based supply can appeal to customers seeking diversified sources, while its share price tends to be influenced by iodine price movements and general LSE sentiment.
Key risks
Key risks include volatility in iodine prices, which can materially affect revenue and margins. The company depends on access to brine from oil and gas operations, so changes in local drilling activity, partner arrangements or water flows can affect output. Plant performance, construction delays and cost inflation are further considerations, as is competition from much larger global producers. LSE shares can be relatively illiquid and prone to sharp price movements.
What to watch next
Investors will likely watch for updates on iodine production volumes, the commissioning of any new IOsorb plants and the direction of iodine prices. The performance of the specialty chemicals division and the company's cash generation will also be important. The next set of results should provide a clearer view of how the business is balancing growth investment with financial strength.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...